Swedish Biotech Delegation to Hong Kong, Shanghai and BioChina 2027

Hong Kong 4-5 March | Shanghai 8-9 March | Suzhou (BIOCHINA) 10-12 March

Build commercial relationships and gain first-hand insight into the biotech ecosystems of Hong Kong and Mainland China

Business Sweden and SwedenBIO invite Swedish biotech companies to join the Swedish Biotech Delegation to Hong Kong, Shanghai and BIOCHINA 2027.

Designed for innovative biotech and life science companies, the delegation provides direct exposure to investors, pharmaceutical and biotech companies, research organisations and innovation ecosystems in Hong Kong and Mainland China. The delegation combines official programmes in Hong Kong on 4–5 March and Shanghai on 8–9 March, followed by BIOCHINA 2027 in Suzhou on 10–12 March. The weekend of 6–7 March falls outside the official programme, and participants travel from Hong Kong to Shanghai at their own arrangement.

Why Join?

China has become one of the world’s most important sources of biopharmaceutical innovation. For Swedish companies with strong science and differentiated assets, the region is increasingly relevant for investment dialogue, partnering and co-development.

The delegation provides Swedish biotech companies with opportunities to:

• Gain first-hand insights into biotech ecosystems, innovation priorities and investment landscapes in Hong Kong and Mainland China
• Meet life science investors, pharmaceutical companies, biotech innovators and a regulatory adviser in a group setting
• Learn how international and Chinese companies approach scientific collaboration, co-development and partnering in Asia
• Visit research organisations, biotech parks and innovation platforms
• Take part in BIOCHINA 2027 with one personalised Partnering Pass per company and visibility at a shared Swedish booth
• Expand international networks through delegation activities and networking opportunities

The programme is designed for commercial relationship building, learning and first-hand insights. Official programme meetings are group meetings arranged by Business Sweden, in collaboration with SwedenBIO and the Consulate General of Sweden in Shanghai, and are subject to stakeholder availability; individual company meetings are not arranged.

Participation does not guarantee investment, partnerships, licensing agreements, meetings or other commercial outcomes.

Why Hong Kong, Shanghai and BioChina?

Hong Kong

Hong Kong is the world’s second-largest biotech fundraising platform and combines international connectivity, specialist capital, research institutions and clinical-development capabilities. It provides a natural starting point for dialogue with life science investors and for understanding how capital, research and clinical development connect with Mainland China.

Shanghai

Shanghai is the centre of China’s innovative drug industry, bringing together multinational R&D teams, Chinese biotech companies, investors and major innovation clusters such as Zhangjiang.

BIOCHINA 2027

BIOCHINA in Suzhou is one of the leading biotech events in the Asia-Pacific region. The 2026 edition gathered 33,065 professionals from more than 40 countries and regions, over 400 exhibitors and more than 250 forums, and facilitated 4,456 one-to-one partnering meetings.

Participating companies will receive visibility at a shared Swedish booth of approximately 9 sqm and one personalised BIOCHINA Partnering Pass per company.

The designated pass holder can use BIOCHINA’s official partnering platform to identify organisations and submit the company’s own meeting requests. Business Sweden and SwedenBIO do not submit requests on behalf of participants. Meetings remain subject to the counterpart’s acceptance, mutual interest and availability.

Delegation Overview

4–5 March 2027
Official delegation program in Hong Kong

6–7 March 2027
Free weekend in Hong Kong or Shanghai
Participants may choose to remain in Hong Kong or travel to Shanghai at their own discretion. This period falls outside the official delegation program, and arrangements and expenses are not included.

8–9 March 2027
Official delegation program in Shanghai

10–12 March 2027
Participation in BIOCHINA 2027 at Suzhou International Expo Center

The detailed agenda and participating stakeholders will be finalized based on the delegation’s composition, stakeholder availability and participating companies’ priorities.

Who Should Participate?

The delegation is relevant for Swedish biotech and life science companies that:

• Develop innovative therapeutics, platforms, enabling technologies or research services
• Are exploring investment, scientific collaboration or strategic partnerships
• Seek dialogue with pharmaceutical companies, biotech innovators and investors in Asia
• Want to better understand biotechnology trends, innovation ecosystems and partnering activity in Asia

Participation Fee

SEK 35,000 per SME | SEK 70,000 per non-SME

SwedenBIO members receive a 15% discount: SEK 29,750 for SMEs and SEK 59,500 for non-SMEs, excluding VAT.

The participation fee covers up to two representatives per participating company.

The participation fee includes:

• Participation in the official Hong Kong and Shanghai delegation programs
• Group meetings, briefings and site visits included in the official program
• Lunches included in the official Hong Kong and Shanghai programs
• Group transportation between scheduled activities in Hong Kong and Shanghai
• Group transportation¹ between Shanghai and Suzhou at the time specified in the official delegation itinerary
• Scheduled group transportation from the designated delegation hotel to the BioChina venue in Suzhou
• Networking activities and receptions included in the official program
• Shared Swedish booth² at BIOCHINA (approx. 9 sqm), with company logos on a joint logo wall and the opportunity to show a short company video
• One personalized BioChina Partnering Pass per participating company³
• Company profiling for the group programme

The participation fee does not include:

• International and domestic flights, airport transfers and accommodation
• Arrangements and expenses outside the official delegation program
• Visa, travel insurance and personal expenses
• Individual transportation or travel outside scheduled group arrangements
• Additional BioChina passes, exhibition, sponsorship or speaking packages

¹ Shanghai–Suzhou transfer: The included group transportation between Shanghai and Suzhou applies only to the scheduled delegation transfer. Participants choosing to travel independently, at a different time or by another route must arrange and pay for their own transportation.

² Swedish presence at BioChina: Due to the booth’s limited footprint, individual roll-ups, backdrops or product displays cannot be accommodated. 

³ BioChina Partnering Pass: One personalized pass is included per participating company and assigned to one representative. Additional passes must be purchased separately at the participating company’s own expense.

De Minimis and SME Regulation

The Participant Company guarantees that it has not received or been granted public support classified as “de minimis aid” exceeding EUR 300,000 during the last three years, including this assignment.

For the SME participation fee, the Participant Company must qualify as an SME according to the European Commission’s definition.

Registration

Registration deadline: Friday, 27 November 2026

Register by the deadline to secure your place.